Close Menu
October 29, 2020

How to Train Your DRAGEN for Pathology Informatics

Genome Webinar

Laboratory Director,
Xing Cancer Care

Illumina’s BaseSpace Sequence Hub (BSSH) supports primary and secondary analysis of massively parallel sequencing data and can be applied to gene panel data that is generated as part of a clinical cancer assay performed in a pathology lab.

In this webinar, Lynn Fink of Xing Cancer Care will discuss how her ISO15189-accredited lab has used BSSH to support informatics data analysis as part its routine testing and will share details of why the lab chose this platform over other options.

In particular, Lynn will share how the lab uses the BSSH-hosted DRAGEN (Dynamic Read Analysis for Genomics) apps — Enrichment, Germline, and Somatic — to perform in-depth coverage analyses of a 1,000 cancer gene panel, germline alteration calling, and tumor-normal paired somatic alteration calling, respectively. These apps support about 95 percent of the lab’s analytical needs.

Sep
24

NTRK fusions are oncogenic drivers in a variety of tumors.

Oct
14
Sponsored by
Inivata

Circulating tumor DNA (ctDNA) can allow clinicians and researchers to better understand which patients are at high risk of recurrence and should be offered intensified chemotherapy or selected for clinical trials.

Oct
29

Illumina’s BaseSpace Sequence Hub (BSSH) supports primary and secondary analysis of massively parallel sequencing data and can be applied to gene panel data that is generated as part of a clinical cancer assay performed in a pathology lab.

Nov
05

This webinar will provide an overview of novel proximal and distal sampling methods that have promise to improve patient outcomes from esophageal cancer.